Delivery Order SPE2DB20D6037-SPE2DB25FTWC0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a firm fixed-price delivery order valued at $1,036.32 by the Defense Logistics Agency (DLA) on August 12, 2025, with completion expected by August 13, 2025. The contract covers the supply of MOVIPREP powder packets, a bowel preparation medication, with performance of work to occur in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, allowing the company to compete on...
- This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.30 firm fixed-price contract is for the delivery of MOVIPREP POWDER PACKETS, with a completion date of June 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,230.97, is for the supply of MOVIPREP powder packets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.96 contract is for the supply of MOVIPREP powder packets, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which allows the agency to place orders for a comprehensive range of pharmaceutical items to support the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,781.90 contract is for the delivery of MOVIPREP POWDER PACKETS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,001.76 and has an ultimate completion date of May 10, 2024. The contract is for the delivery of MOVIPREP powder packets, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,505.84 contract is to provide MOVIPREP powder packets, a medication used for bowel preparation procedures. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency's Medical Supply Chain division on July 23, 2025. This delivery order, with an ultimate completion date of July 24, 2025, represents a single task order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid...
- The Defense Logistics Agency awarded a delivery order valued at $2,667.01 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 20, 2025. The contract calls for the delivery of Eohilia 2 mg/10 mL stick pack (10 mL units) to a location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under a firm fixed-price structure with no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $9,889.86 from the Defense Logistics Agency's Medical Supply Chain division on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB25FTWC0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,036.32 to DMS Pharmaceutical Group Inc. for MOVIPREP powder packets, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was executed on August 11, 2025, with no set-aside designation applied. The place of performance is identified as Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, is well-positioned to fulfill this requirement given its extensive experience distributing pharmaceutical products to federal healthcare systems. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The SPE2DB program vehicle enables the agency to procure firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to provide branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/11/25 |